Diabetes Mellitus Induces Bone Marrow Microangiopathy

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2010 Jan 1

PMID 20042708

Citations 97

Authors

Atsuhiko Oikawa

Mauro Siragusa

Federico Quaini

Giuseppe Mangialardi

Rajesh G Katare

Andrea Caporali

Jaap D van Buul

Floris P J van Alphen

Gallia Graiani

Gaia Spinetti

Nicolle Kraenkel

Lucia Prezioso

Costanza Emanueli

Paolo Madeddu

Affiliations

Soon will be listed here.

Abstract

Objective: The impact of diabetes on the bone marrow (BM) microenvironment was not adequately explored. We investigated whether diabetes induces microvascular remodeling with negative consequence for BM homeostasis.

Methods And Results: We found profound structural alterations in BM from mice with type 1 diabetes with depletion of the hematopoietic component and fatty degeneration. Blood flow (fluorescent microspheres) and microvascular density (immunohistochemistry) were remarkably reduced. Flow cytometry verified the depletion of MECA-32(+) endothelial cells. Cultured endothelial cells from BM of diabetic mice showed higher levels of oxidative stress, increased activity of the senescence marker beta-galactosidase, reduced migratory and network-formation capacities, and increased permeability and adhesiveness to BM mononuclear cells. Flow cytometry analysis of lineage(-) c-Kit(+) Sca-1(+) cell distribution along an in vivo Hoechst-33342 dye perfusion gradient documented that diabetes depletes lineage(-) c-Kit(+) Sca-1(+) cells predominantly in the low-perfused part of the marrow. Cell depletion was associated to increased oxidative stress, DNA damage, and activation of apoptosis. Boosting the antioxidative pentose phosphate pathway by benfotiamine supplementation prevented microangiopathy, hypoperfusion, and lineage(-) c-Kit(+) Sca-1(+) cell depletion.

Conclusions: We provide novel evidence for the presence of microangiopathy impinging on the integrity of diabetic BM. These discoveries offer the framework for mechanistic solutions of BM dysfunction in diabetes.

Citing Articles

Steroids and Malignancy Increase Local Heparanase and Decrease Markers of Osteoblast Activity in Bone Tissue Microcirculation.

Asayag K, Peled E, Assalia M, Crispel Y, Yanovich C, Cohen H Biomolecules. 2025; 14(12.

PMID: 39766213 PMC: 11673960. DOI: 10.3390/biom14121506.

Emerging insights into epigenetics and hematopoietic stem cell trafficking in age-related hematological malignancies.

Xinyi Y, Vladimirovich R, Beeraka N, Satyavathi A, Kamble D, Nikolenko V Stem Cell Res Ther. 2024; 15(1):401.

PMID: 39506818 PMC: 11539620. DOI: 10.1186/s13287-024-04008-4.

Role of Neurotransmitters in Steady State Hematopoiesis, Aging, and Leukemia.

Beeraka N, Basappa B, Nikolenko V, Mahesh P Stem Cell Rev Rep. 2024; 21(1):2-27.

PMID: 38976142 DOI: 10.1007/s12015-024-10761-z.

Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging.

Yang L, Li D, Yan Y, Yang Q, Li L, Zha Y J Diabetes Investig. 2024; 15(5):584-593.

PMID: 38240456 PMC: 11060156. DOI: 10.1111/jdi.14145.

Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nerves.

Mauricio D, Gratacos M, Franch-Nadal J Cardiovasc Diabetol. 2023; 22(1):314.

PMID: 37968679 PMC: 10652502. DOI: 10.1186/s12933-023-02056-3.

References

Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

Li X, Hu Z, Jorgenson M, Wingard J, Slayton W . Bone marrow sinusoidal endothelial cells undergo nonapoptotic cell death and are replaced by proliferating sinusoidal cells in situ to maintain the vascular niche following lethal irradiation. Exp Hematol. 2008; 36(9):1143-1156. DOI: 10.1016/j.exphem.2008.06.009. View

Levesque J, Hendy J, Takamatsu Y, Simmons P, Bendall L . Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 2003; 111(2):187-96. PMC: 151860. DOI: 10.1172/JCI15994. View

Zhang J, Niu C, Ye L, Huang H, He X, Tong W . Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-41. DOI: 10.1038/nature02041. View

Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I . Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004; 431(7011):997-1002. DOI: 10.1038/nature02989. View

Avecilla S, Hattori K, Heissig B, Tejada R, Liao F, Shido K . Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004; 10(1):64-71. DOI: 10.1038/nm973. View

Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K . Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006; 12(4):446-51. DOI: 10.1038/nm1388. View

Asahara T, Kawamoto A . Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol. 2004; 287(3):C572-9. DOI: 10.1152/ajpcell.00330.2003. View

van Buul J, Voermans C, van den Berg V, Anthony E, Mul F, van Wetering S . Migration of human hematopoietic progenitor cells across bone marrow endothelium is regulated by vascular endothelial cadherin. J Immunol. 2002; 168(2):588-96. DOI: 10.4049/jimmunol.168.2.588. View

10.

Kiel M, Morrison S . Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008; 8(4):290-301. DOI: 10.1038/nri2279. View

11.

Naveiras O, Nardi V, Wenzel P, Hauschka P, Fahey F, Daley G . Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature. 2009; 460(7252):259-63. PMC: 2831539. DOI: 10.1038/nature08099. View

12.

Gadau S, Emanueli C, Linthout S, Graiani G, Todaro M, Meloni M . Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia. 2006; 49(2):405-20. DOI: 10.1007/s00125-005-0103-5. View

13.

Jang Y, Sharkis S . A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007; 110(8):3056-63. PMC: 2018677. DOI: 10.1182/blood-2007-05-087759. View

14.

Fischer C, Schneider M, Carmeliet P . Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb Exp Pharmacol. 2006; (176 Pt 2):157-212. DOI: 10.1007/3-540-36028-x_6. View

15.

Wang Q, Wang B, Huang Y, Dai G, Li W, Yan Q . Purification and growth of endothelial progenitor cells from murine bone marrow mononuclear cells. J Cell Biochem. 2007; 103(1):21-9. DOI: 10.1002/jcb.21377. View

16.

Kiel M, Yilmaz O, Iwashita T, Yilmaz O, Terhorst C, Morrison S . SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121(7):1109-21. DOI: 10.1016/j.cell.2005.05.026. View

17.

Tothova Z, Kollipara R, Huntly B, Lee B, Castrillon D, Cullen D . FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007; 128(2):325-39. DOI: 10.1016/j.cell.2007.01.003. View

18.

El-Osta A, Brasacchio D, Yao D, Pocai A, Jones P, Roeder R . Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008; 205(10):2409-17. PMC: 2556800. DOI: 10.1084/jem.20081188. View

19.

Jin D, Shido K, Kopp H, Petit I, Shmelkov S, Young L . Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med. 2006; 12(5):557-67. PMC: 2754288. DOI: 10.1038/nm1400. View

20.

Chen C, Liu Y, Liu R, Ikenoue T, Guan K, Liu Y . TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med. 2008; 205(10):2397-408. PMC: 2556783. DOI: 10.1084/jem.20081297. View